NGM Biopharmaceuticals, Inc. (NGM): Price and Financial Metrics
NGM Price/Volume Stats
| Current price | $1.54 | 52-week high | $4.69 |
| Prev. close | $1.56 | 52-week low | $0.60 |
| Day low | $1.54 | Volume | 2,390,800 |
| Day high | $1.57 | Avg. volume | 1,467,160 |
| 50-day MA | $1.54 | Dividend yield | N/A |
| 200-day MA | $1.54 | Market Cap | 128.53M |
NGM Stock Price Chart Interactive Chart >
NGM Biopharmaceuticals, Inc. (NGM) Company Bio
NGM Biopharmaceuticals, Inc. engages in the discovery and development of therapeutics for major diseases with an initial focus on cardio-metabolic and liver diseases. Its portfolio if composed of product candidates which focuses on non-alcoholic steatohepatitis, type 2 diabetes, obesity, oncology and age-related macular degeneration. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.
NGM Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 79.28% |
| 3-year | -91.30% |
| 5-year | N/A |
| YTD | 79.28% |
| 2023 | -82.89% |
| 2022 | -71.65% |
| 2021 | -41.54% |
| 2020 | 63.85% |
| 2019 | N/A |
Loading social stream, please wait...